XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions (Narrative) (Details)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 31, 2021
USD ($)
Jan. 31, 2021
USD ($)
right
$ / shares
Feb. 29, 2020
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Business Acquisition [Line Items]                    
Acquired IPR&D Expense         $ 25.0   $ 241.8 $ 324.3 $ 294.1  
Cash paid, net of cash acquired               747.4 849.3  
Goodwill         $ 3,884.2     3,884.2   $ 3,766.5
Repayments of long-term debt               $ 0.0 $ 276.3  
Kumquat Biosciences Inc. | Subsequent Event                    
Business Acquisition [Line Items]                    
Payments to acquire businesses $ 50.0                  
Consideration transferred, equity interests purchased 20.0                  
Kumquat Biosciences Inc. | Subsequent Event | Forecast                    
Business Acquisition [Line Items]                    
Acquired IPR&D Expense       $ 55.0            
Prevail Therapeutics Inc.                    
Business Acquisition [Line Items]                    
Business acquisition, share price (in dollars per share) | $ / shares   $ 22.50                
Cash paid, net of cash acquired   $ 747.4                
Consideration transferred, number of contingent value rights | right   1                
Contingent value right, additional price per share (up to) (in dollars per share) | $ / shares   $ 4.00                
Contingent value right, additional price per share, aggregate amount   $ 160.0                
Contingent value right, monthly reduction (in cents per share) | $ / shares   $ 0.083                
Goodwill   $ 118.8                
Acquired IPR&D   824.0                
Deferred income taxes assumed   $ 98.0                
Dermira                    
Business Acquisition [Line Items]                    
Purchase price     $ 849.3              
Goodwill     86.8              
Acquired IPR&D     1,200.0              
Deferred income taxes assumed     49.5              
Long-term debt assumed     $ 375.5              
Repayments of long-term debt           $ 276.2        
Protomer Technologies Inc. | Subsequent Event                    
Business Acquisition [Line Items]                    
Payments to acquire businesses $ 61.6                  
Protomer Technologies Inc. | Subsequent Event | Forecast                    
Business Acquisition [Line Items]                    
Acquired IPR&D Expense       $ 65.0